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The presence of lesions in the liver of mice is associated with the infection of these mice with the common bile
duct-dwelling cestode, Hymenolepis microstoma.

Lesions de-

velop even though there is no direct contact between the
cestodes and the liver.

It was found in this investigation

that administration to mice of Tyrode's solution, in which
cestodes had been incubated for 24 hr, resulted in liver
lesions comparable to those observed in normal infections.
The administration of the causative substance by either per
os intubation or intraperitoneal injection produced similar
lesions.

Further studies revealed that the active lesion -

causing substance was isolated in a lipid extract of the
metabolic by-products.

It was also determined that the ac-

tive material had a molecular weight of less than 10,000.

INTRODUCTION

Dobrovolskaia-Zavadskaia and Kobosieff (1927) first reported the presence of lesions in the liver of mice infected
with the bile duct-dwelling cestode, Hymenolepis microstoma.
Chandler (1943), Dvorak, et al. (1961), Litchford (1963),
Bogitsh (1966), and Gleason (1971) have subsequently reported various aspects of the formation of the lesions and
described histopathology associated with the infection of
mice by this cestode.

It has been postulated by the above

authors that lesion formation may be caused by such factors
as parasite-induced host nutritional deficiencies, biliary
obstruction, or toxic-metabolic by-products.

Gleason (1971)

reported fully developed focal lesions as early as 6 days
after infection, indicating that actual formation of the
lesion begins prior to this time.

The occurrence of lesions

at such an early stage in the infection would seem to exclude blockage of the bile duct and parasite -induced host
nutritional deficiencies as possible mechanisms for the
formation of the lesions.
This study was initiated to investigate the possibility
that metabolic by-products were the causative agent(s) of
lesion formation in the liver.

Preliminary studies indicated

that this was the etiology of the lesion formation and fur -
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ther experiments were then conducted to study the effects
upon different strains of mice and upon different routes of
experimental administration.

Also, preliminary character-

ization of the causative substance was done by preparation
of lipid and protein extracts and by determination of the
approximate molecular weight using ultrafiltration techniques.

MATERIALS AND METHODS

The Hymenolepis microstoma used for this study were obtained from a stock maintained in the Department of
Parasitology and Laboratory Practices at the University of
North Carolina.

The cestodes were routinely maintained in

mice and the intermediate host, the confused flour beetle,
Tribolium confusum.

This was done by removing gravid pro-

glottids from mature worms found attached in the common bile
duct of the mouse host and placing the proglottids on strips
of filter paper which were placed in a petri dish with beetles.

The beetles had been starved for 5-8 days prior to
After the beetles had eaten

being given the proglottids.

the proglottids, they were transferred to baby food jars
half-filled with flour and containing a few raisins for moisture.

At room temperature cysticercoids become infective in

8-10 days.
stock mice.

Cysticercoids 2-4 weeks old were used to infect
Beetles were dissected and the cysticercoids

collected in saline (0.9% NaC1).

Ten cysticercoids were ad-

ministered to each mouse per os using a 1 -cc tuberculin syringe attached to a blunted, slightly curved 16-gauge needle.
Following intubation the needle was flushed with saline and
the washings checked under a dissecting microscope to insure
that all cysticercoids had been delivered.
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Stock mice were
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housed until needed for continuing the life cycle or experimental use.
The experimental study involved several facets.

How-

ever, certain techniques common to all facets were employed
in the investigation.

In order to obtain cestodes for the

studies, white laboratory mice were infected per os with 15
cysticercoids each.

(A particular inbred strain of mouse

was not used for this part of the procedure because of the
excessive cost.)

After the worms had been in the mice for

the time dictated by the experimental procedures to be described later, the mice were killed by cervical dislocation,
the H. microstoma removed from the common bile duct and
placed in an antibiotic solution containing 1 cc Combiotic/
99 cc saline.

Combiotic (Chas. Pfizer & Co., New York) is

an aqueous solution containing 200,000 units procaine penicillin G and 0.25 g of dihydrostreptomycin per 1 cc.

The

worms were left in this solution for approximately 30 min
in order to insure bacteria-free cestodes.

Using aseptic

techniques, the worms were then removed from the antibiotic
solution and placed in sterile petri dishes which contained
Tyrode's solution (Rohrbacher, 1957), in the approximate
ratio of 3 worms/ml.

The worms were then incubated in this

medium at 37° C for a period of 24 hr.
viable following incubation.

The cestodes remained

The Tyrode's solution con-

taining the incubated cestodes was then filtered through a
450 mu Millipore filter.

Filtrate samples of 0.5 ml were

used to inoculate pour plates of nutrient agar and blood
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agar to check for bacterial contamination of the filtrate.
The filtrate was then pipetted into sterile vials to be used
in the experiments outlined below.
The procedure for determining wet and dry weights of the
cestodes per ml of Tyrode's solution involved using the worm
mass left on the Millipore filter.

All the worm mass was

placed on filter paper to remove as much moisture as possible using this technique.

The worms were then placed in a

pre-dried and pre-weighed 2-in diameter, shallow, aluminum
pan, and weighed on an analytical balance.

The wet weight

was determined by subtracting the weight of the pan from the
weight of the pan and worms.

The pan containing the wet

worm mass was placed for 24 hr in a drying oven maintained
at 85 ° C.

Subsequent to drying, the pan and worms were placed

in a desiccator containing calcium chloride crystals for 2
hr to allow for cooling.

The pan and worms were removed and

immediately weighed on the analytical balance.

The dry

weight was determined by subtracting the pan weight from the
pan and dried -worm weight.

The average worm mass per ml of

Tyrode's solution was calculated.
To determine if the active substance was contained in a
protein fraction of the metabolic by-products produced during the incubation of the worms, proteins were extracted
from the incubation medium using methods described by
Rendina (1971).

A 50-ml aliquot of incubation medium was

placed in one and one -eighth in diameter dialysis tubing
and dialysed against approximately 350 ml of saturated am-
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monium sulfate solution for 24 hr.

The contents in the

dialysis tubing were divided in half and centrifuged in
50-ml plastic centrifuge tubes for 1 hr at 39,100 x gravity
using a Sorvall Superspeed RC2-B Automatic Refrigerated
Centrifuge with an SS -34 rotor head.

At this point the

procedure was discontinued since no protein precipitate was
observed.

Subsequently, fresh medium was analyzed for pro-

teins using the Waddell method cited in Murphy and Kies
(1960).

This technique is a protein specific absorbance

test to determine the mg of protein per ml.

This analysis

was done at 25° C using a Bausch and Lomb Precision
Spectrophotometer.
Extraction of the lipid fraction of the incubation medium was accomplished using the methods described by Rendina
(1971).

A 50-ml aliquot of incubation medium was mixed with

an equal volume of 2:1 methanol -chloroform solution.

The

mixture was centrifuged for 1 hr at 39,100 x gravity as described in the protein extraction procedure.

The resulting

supernatant was collected and an equal volume of 2N KC1 was
added to produce a biphasic system.

The biphasic state was

further delineated by centrifugation for 30 min at 39,100 x
gravity; the upper phase was removed and discarded.

The

lower phase was washed with water in a 100-ml separatory
funnel, again producing a biphasic system.

The lower phase

was collected, placed in a crucible, and the methanol-chloroform mixture evaporated in a 65°C oven.

The lipid fraction

remained in the crucible in approximately 1 ml of solution.

7

This material was reconstituted to a volume of 50 ml with
Tyrode's solution, the total volume including washings of
the crucible.

The Tyrode's solution containing the lipid

fraction was transferred to vials to be used as prescribed
in the experimental procedures for the test of the lipid
fraction of the worm metabolic by-products.
Ultrafiltration was used to determine the molecular
weight range of the active ingredient(s) contained in the
metabolic by-products.

A 50-ml aliquot of incubated medium

was placed in an Amicon Model 52 ultrafiltration cell and
forced through 100,000, 30,000, and 10,000 standard molecular weight filters using pressurized nitrogen.

The cell

was packed in ice during the filtration procedure.

The me-

dium was successively passed through filter sizes of 100,000,
30,000, and 10,000; material left on each filter was resuspended in 50-ml aliquots of fresh Tyrode's solution.

The

filtrate passing through all filter sizes was also collected.
This resulted in 4 molecular weight ranges:

(1) 100,000 and

above; (2) between 30,000 and 100,000; (3) between 10,000
and 30,000; and (4) less than 10,000.

The media containing

the different molecular weight ranges were placed in vials
and used as described in the experimental procedures.
Mice used for the studies as outlined in the experimental procedures were 13-18 g male mice of 2 types:

(1) an in-

bred strain - ICR/DUB - purchased from Flow Research
Laboratories, Dublin, Virginia; and (2) an outbred strain
maintained in the Biology Department, Western Kentucky
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University.
Material to be tested for lesion formation capacity and
control materials were administered by either intraperitoneal
(i.p.) injection or per os (p.o.) intubation as prescribed
by the experimental procedures.

The i.p. injections were

done with a 1 -cc tuberculin syringe and a 27-gauge needle.
The needle was inserted under the skin of the abdomen and
then through the peritoneum anterior to the point of penetration of the skin.
the peritoneal cavity.

The solution was then injected into
For per os administration, a 1 -cc

tuberculin syringe and a slightly curved, blunt 18-gauge
needle were used.

The intubation needle was inserted into

the oral cavity and down the esophagus, and the material was
intubated directly into the stomach.

Between each intubation

of the mice the needle and syrine were flushed with saline
and air dried.
At the end of each experimental injection or intubation
schedule as outlined in the experimental procedures, the mice
were killed by cervical dislocation.
ated and the liver removed.

The mice were eviscer-

The liver was quick-frozen on

the microtome-cryostat (International-Harris Cryostat,
International Equipment Company) and sectioned at a thickness
of 10 microns.

Sections were collected and prepared for

study as described by Gleason (1971).

The sections were

collected on clean microscope slides which had been slightly
warmed.

These were fixed in 10% formalin in 95% ethyl al-

cohol, washed with running tap water, stained with Harris'
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hematoxylin and eosin, dehydrated, cleared in xylene, and
mounted in Permount using #1 cover slips.
Microscopic examination of the prepared slides was followed by taking pictures of representative lesions.

Pic-

tures were taken on Kodak Panatomic-X fine grain black and
white film, using a Wild microscope equipped with an automatic camera.

LO) -11 1-11-1
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EXPERIMENTAL PROCEDURES

Experiment I - Intraperitoneal injection of metabolic byproducts from 10-day -old worms:

Both ICR/DUB and outbred strains of mice were used in
this study.

For each strain, 10 experimental and 5 control

mice were used.

Each experimental mouse was injected i.p.

at 12-hr intervals for 5 days with 1 ml of Tyrode's solution,
in which 10-day-old worms had been incubated for 24 hr, thus
resulting in a total dosage of 10 ml per mouse.

Each con-

trol mouse was injected using the same schedule, but using
incubated Tyrode's solution in which no worms had been maintained.

Twelve to eighteen hr after the 5-day injection

schedule, the mice were killed and liver sections were collected and prepared for microscopic examination.

Experiment II - Per os administration of metabolic byproducts from 10-day-old worms:

This test was initiated to determine if mode of administration affected the ability of the metabolic by-products
to cause liver lesions.

Both 1CR/DUB and outbred strains

of mice were employed in this experiment.

Ten experimental

and five control mice of each strain were used.
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Each exper-
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imental mouse was intubated p.o. at 12-hr intervals with 1
ml of Tyrode's solution in which 10-day-old cestodes had
been maintained for 24 hr.

The total amount of solution

administered to each mouse over the S-day period was 10 ml.
The control mice were intubated p.o. at 12-hr intervals for
5 days with 1 ml of incubated Tyrode's solution in which no
cestodes had been maintained.

The mice were killed 12-18 hr

after the final dose had been administered, and liver sections were collected and prepared for microscopic examination.

Experiment III - Intraperitoneal injection of metabolic
by-products from 30-day-old worms:

This study was performed to determine if the age of the
worms affected the ability of the metabolic by-products to
cause the liver lesions.
of mice were used.

Both ICR/DUB and outbred strains

For each strain, 10 experimental and 5

control mice were used.

Each experimental mouse was inject-

ed i.p. at 12-hr intervals for 5 days with 1 ml of Tyrode's
solution in which 30-day -old cestodes had been maintained
for 24 hr.

The techniques for the treatment of control mice

were identical to those employed in Exp. I.
of solution given to each mouse was 10 ml.

The total amount
Twelve to eigh-

teen hr after termination of the injection schedule, all
mice were killed; liver sections were collected and prepared for microscopic examination.
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Experiment IV - Per os administration of lipid extract of
metabolic by-products from 10-day-old
worms:

This experiment was performed to determine if the lesion -causing substance was contained in the lipid extract
of the worm metabolic by-products.
were employed for this test.

ICR/DUB strain mice

Each of 5 experimental mice

were intubated 2_2r os at 12-hr intervals for 5 days with
1 ml of lipid extract, for a total dosage of 10 ml.

Two

control groups of 5 mice each were used in this experiment.
Each mouse of the first control group was given 1 ml of
Tyrode's solution, in which worms had been incubated, at 12hr intervals for 5 days to insure that the lesion-causing
material was present.

The mice of the second control group

were given Tyrode's solution, in which no worms had been incubated, on which the lipid extraction procedure had been
performed.

This material was administered using the same

procedure and schedule as the first control group.

The

second control group was used to insure that lesion formation was a result of substance contained in the lipid extract and not an artifact produced by the extraction procedure.

The mice of the different groups were killed 12-18

hr after the last intubation, and liver sections were collected and prepared for histologic studies.

Experiment V - Per os administration of various molecular
weight ranges of metabolic by-products
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from 10-day-old worms:

The purpose of this experiment was to determine the approximate molecular weight of the lesion -causing substance.
The strain of mouse used in this experiment was the ICR/DUB
type.

Five experimental mice were used for each of the mo-

lecular weight ranges tested.

These ranges were:

(1) less

than 10,000; (2) greater than 10,000, but less than 30,000;
(3) greater than 30,000, but less than 100,000; and (4)
greater than 100,000.

Each experimental mouse was given,

per os, 1 ml of the designated molecular weight range fraction at 12-hr intervals for 5 days.

The procedure for treat-

ment of the control group used in this experiment was similar to that described for the first control group in Exp.
IV.

Following final intubation, the mice were killed, and

liver sections were collected and prepared for microscopic
examination.

Experiment VI - Liver lesions caused by worm infection:

The experiment was conducted to determine if, in the
ICR/DUB mice, the lesions formed in a worm infection were
similar to those induced passively by injection or intubation of worm metabolic by-products.

Ten experimental ICR/

DUB mice were intubated, per os, with 6 cysticercoids each,
according to the procedures described for routine maintenance of the cestodes.

Five days after infection 5 of the

mice were killed; liver sections were collected and prepared
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for microscopic examination to study the appearance of early
lesions.

On Day 11 of the infection, the remaining 5 ex-

perimental mice were killed.

Liver sections were collected

and prepared for microscopic examination to study fully developed lesions.

RESULTS

The aseptic techniques employed in this study to insure sterility of the incubation media were effective and
contamination of the media did not occur.

Results of in-

oculating aliquots of the media on nutrient agar and blood
agar pour plates to test for bacterial growth were negative
with the exception of one plate upon which only one contaminant colony was observed.
The average wet weight of the worms was 2.99 mg, resulting in an average of 11.55 mg of wet wt per ml of incubation medium.

The average dry weight of the worms was

0.74 mg, resulting in an average of 2.86 mg of dry wt per
ml of incubation medium.
Analysis by the Waddell method, cited in Murphy and
Kies (1960), of the Tyrode's solution in which cestodes had
been maintained revealed very small amounts of protein.
The average protein content was only 0.846 mg/ml.

This

small amount resulted in no perceivable precipitate using
the salting out method and thus a protein extract was not
prepared.
Microscopic examination of the prepared slides obtained
in Exp. I, which involved i.p. injection of metabolic byproducts from 10-day-old worms, revealed lesion formation
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in the liver parenchyma of the experimental animals.

Both

strains of mice tested showed lesion formation; however,
the response in the outbred strain was somewhat greater
In the outbred

than that observed in the ICR/DUB strain.

strain, 9 of 10 mice had liver lesiors, while 6 of 10 ICR/
DUB mice had lesions.

None of the control mice for either

experimental group showed evidence of lesion formation.
Lesion formation was quite similar to that described
by Gleason (1971) for a worm infection.

Early lesion for-

mation was characterized by an infiltration and accumulation of leucocytes into an area of the liver where deterioration and degeneration of hepatic cells had previously
begun (Fig. 1).

The predominant leucocyte type appeared

to be polymorphonuclear leucocytes (PMN's).
Further lesion development involved even more degradation and degeneration of hepatic tissue eventually leading to well-developed focal lesions (Figs. 2-3).

These

well-developed lesions contained infiltrations and accumulations of leucocytes- predominantly PMN's, accumulations
of cellular debris, and areas of extreme internal hemorrhaging.

There were also instances where no hemorrhaging

was evident (Fig. 4).

Many of the well-developed lesions

exhibited evidence of the deposition of connective tissue
around the necrotic tissue of the lesion.

Often this con-

nective tissue deposition was quite pronounced (Fig. 5).
Large accumulations of leucocytes- predominantly PMN'swere observed thoughout the connective tissue areas (Fig. 6).
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Figure 1.

Early lesion in the liver of a mouse resulting
from
obtained
per os intubation of metabolic by-products
from 10-day-old Hymenolepis microstoma.
Note the accumulation of leucocytes (predominantly
polymorphonuclear leucocytes) at the site of degenerating hepatic cells.
x 300.

Figure 2.

Advanced lesion in the liver of a mouse resulting
from Rer? os intubation of metabolic by-products
obtained from 10-day-old Hymenolepis microstoma.
As the necrosis of hepatic cells spreads, there is
an increase in cellular debris within the lesion,
sometimes hemorrhaging into the lesion (as illustrated in this photomicrograph), and an increase
in the number of leucocytes, both in the lesion
and in the surrounding tissue.
x 300.
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Figure 3.

Figure 4.

Advanced lesion in the liver of a mouse resulting
from intraperitoneal injection of metabolic byproducts obtained from 10-day -old Hymenolepis
microstoma. Note the similarity between this lesion and the advanced lesion induced by per os
intubation as shown in Fig. 2.
x 300.

Advanced lesion in the liver of a mouse resulting
from intraperitoneal injection of metabolic byproducts obtained from 10-day-old Hymenolepis
microstoma. The lesion has developed without apparent hemorrhaging.
x 300.
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Figure 5.

Advanced lesion in the liver of a mouse resulting
from per os intubation of metabolic by-products
obtained from 10-day-old Hymenolepis microstoma.
Note the deposition of connective tissue around
the lesion. x 150.

Figure 6.

Connective tissue surrounding a lesion in the
liver of a mouse resulting from per os intubation of metabolic by-products obtained from 10day-old Hymenolepis microstoma. Normal liver
tissue can be observed in the lower left corner
of the figure. x 500.
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What appeared to be coalescing of lesions was also evident in the experimental mice.

This coalescing appeared

to occur in an area where smaller focal lesions were in
close proximity (Fig. 7) and expanded in size until they
appeared to coalesce to form a much larger lesion (Fig. 8).
The experimental mice of Exp. I displayed the various forms
and stages of lesion formation just described.
The liver tissue of control mice showed no signs of
heavy leucocyte infiltration and accumulation as would be
the case in early lesion formation.

Also, there was no

evidence of deterioration and degeneration of hepatic cells
(Fig. 9).
Liver lesion formation in Exp. II, involving ELL os
administration of metabolic by-products from 10-day -old
worms, was similar to that described in Exp. I.

Again, both

strains of mice, outbred and ICR/DUB, showed evidence of
liver lesions.

In the outbred strain, 8 of 10 mice had

lesions, while 7 of 10 ICR/DUB mice had lesions formed.

No

control mice showed evidence of lesions.
Examination of slides prepared from mice used in Exp.
III, in which metabolites from 30-day-old worms were injected intraperitoneally, revealed results which were markedly different from those found in Exp. I and II.

Distinct,

well-developed lesions were found in neither outbred nor
ICR/DUB mice.

Evidence of possible lesion development was

observed in only 3 outbred and 2 ICR/DUB mice.

In these

mice, there were a few instances of what might have been
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Figure 7.

Advanced lesions in the liver of a mouse resulting
from per os intubation with metabolic by-products
obtained from 10-day-old Hymenolepis microstoma.
Two lesions have formed in close proximity to one
another. x 300.

Figure 8.

Advanced lesion in the liver of a mouse resulting
from per os intubation with metabolic by-products
obtained from 10-day-old Hymenolepis microstoma.
The 3 dark areas (within the lesion) of leucocyte
accumulation are apparently the sites of individual lesion formation which later coalesced as the
lesions increased in size. x 150.
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Figure 9.

Normal appearing liver tissue of a control mouse
injected intraperitoneally with Tyrode's solution.
There is no evidence of any stage of lesion formation. x 300.

Figure 10.

Advanced lesion in the liver of a mouse resulting
from per os intubation of a lipid extract of the
metabolic by-products obtained from 10-day -old
Hymenolepis microstoma. Lesion formation is similar to that previously described.
x 300.
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construed as very early lesion formation or perhaps only
extensive leucocyte infiltration.

Control mice had no ev-

idence of lesion formation.
In Exp. IV, per os administration of a lipid extract
of metabolic by-products from 10-day-old worms resulted in
lesion formation in the liver of 4 of 5 of the experimental
mice.

Observed lesions were similar to those described pre-

viously (Fig. 10).

No lesion formation was evident in ei-

ther of the control groups employed in this experiment.
Of the 4 molecular weight ranges tested in Exp. V, only
1 range resulted in formation of lesions when administered
per os to the experimental mice (Fig. 11).
less than 10,000 molecular weight filtrate.
of lesions resulted in the other 3 ranges:

This was the
No formation
(1) between

10,000 and 30,000; between 30,000 and 100,000; and (3)
greater than 100,000.

Control mice showed no evidence of

lesions.
The lesions formed as a result of 6-worm infections
in the experimental mice of Exp. VI were markedly similar
to those which were passively induced with metabolic byproducts in Exp. I, II, IV, and V.

Comparison of Fig. 12

with Fig. 2,3,4,7,10, and 11 readily demonstrated this fact.
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Figure 11.

Advanced lesion in the liver of a mouse resulting
from per os intubation of the less than 10,000
molecular weight filtrate of metabolic by-products
obtained from 10-day-old Hymenolepis microstoma.
The lesion has all the characteristics of lesions
formed as a result of administration of the metabolic by-products not subjected to ultrafiltration. x 300.

Figure 12.

Advanced lesion in the liver of a mouse infected
with 6 Hymenolepis microstoma. The lesion is
comparable to lesions induced by administration
of worm metabolic by-products.
x 300.

DISCUSSION

The results of this study indicated that the causative agent of liver lesion formation in mice infected with
Hymenolepis microstoma is one or more metabolic by-products.
The study also revealed that the causative agent is equally
effective by either intraperitoneal injection or per os
intubation as the mode of administration.

It was also de-

termined that the causative agent is contained within a
lipid extract and has a molecular weight of less than 10,000.
Experiment I and II (i.p. and p.o. administration, respectively, of metabolic by-products from 10-day -old worms)
demonstrated that the mode of administration did not affect
lesion formation.

It is significant that the causative

agent, when administered p.o., was not deactivated or destroyed by the digestive juices and acidic conditions of the
stomach.

Consequently, the causative agent appears to be

relatively stable and thus would be easier to work with than
some other compound with less stability.
The 2 different modes of administration also lend themselves to different routes of absorption and transportation
to the liver of the lesion-causing agent.

The intraper-

itoneally injected by-products could have been carried by
the lymph to the circulatory system and then carried to the
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liver, or the by-products could have been absorbed into the
blood vessels of the peritoneal cavity.

The per os adminis-

tered by-products were more than likely absorbed by the
intestinal villi and then carried by the hepatic portal system to the liver.

Irregardless of the means of transport to

the liver, the results of both modes of administration were
the same:

liver lesion formation similar to that described

for mice actually infected with H. microstoma.
It is significant that the different stages of induced
lesion formation using metabolic by-products were very similar to those observed in mice infected with H. microstoma,
thus indicating a common origin.
Experiment III, using metabolic by-products from 30-day old worms, was performed in order to determine if the
age of
the worms affected lesion formation, since Gleason (1971)
reported a decrease in lesion formation after about Day 20
of the infection.

Results of this experiment indicated that

the age of the worm did affect the lesion formation since
the metabolic by-products from 30-day -old worms did not
cause well -developed, observable lesions within the parame
ters
of the experimental technique employed.
be a possible explanation for this.

There may, however,

Throughout all the ex-

periments, the worm mass per ml of Tyrode's solution used
was held as constant as possible.

Consequently, the majority

of the worm mass used in Experiment III consisted of mature
and gravid proglottids whereas in the experiments using
10day-old worms, the worm mass consisted predominantly of im-
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mature proglottids.

Due to these circumstances, it is fea-

sible that in Experiment III the majority of the metabolic
by-products were of the type excreted from mature and gravid
proglottids whereas the metabolic by-products used in the
experiments with 10-day-old worms were from immature proglottids.

This could possibly be tested by using metabolic

by-products obtained from 30-day-old worms from which the
mature and gravid proglottids had been previously removed
or by using metabolic by-products from an increased worm
mass of 30-day-old worms per ml of Tyrode's solution used,
thereby compensating for the decrease in immature proglottids
in Experiment III.

By use of either of these procedures, one

might reasonably expect the same results, in respect to
lesion formation, that was obtained using metabolic by-products from 10-day-old worms.

It also seems probable that the

number of immature proglottids would remain relatively
constant during worm development.

Consequently, one would

not expect the amount of lesion -causing metabolic by-products
given off by the immature proglottids to decrease as the age
of the worms increased in an infection of mice with H.
microstoma.

Therefore, a possible explanation for decrease

in the rate of lesion formation in infected mice after Day 20
of an infection with H. microstoma may be due to a partial
humoral immunity to the metabolic by-products carried by the
circulatory system rather than due to the age of the worms.
In experiment IV, the lesions formed by use of a lipid
extract were quite similar to those observed in all other
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experiments.

The route of administration, per os, demon-

strated once again that the causative agent of lesion formation contained in the lipid extract was not degraded or
destroyed in the stomach.
Experiment V, in which 4 molecular weight ranges of the
metabolic by-products were tested, yielded results which
showed the causative agent to be relatively small.

The le-

sion-causing agent was found in the less than 10,000 molecular weight range and yielded lesions comparable to those
observed in the other experiments.
Experiment VI was performed to determine if induced lesions (using worm metabolic by-products) were comparable to
lesions formed in an infection with H. microstoma and to
provide supporting evidence that worm metabolic by-products
were instrumental in lesion formation in the liver.

The

experimental mice, which were given 6-worm infections, were
killed 5 and 11 days after initial infection.

This was done

in order to provide a time range for lesion formation in
worm -infected mice similar to that for the lesion-induced
mice.

Lesions formed in this experiment were comparable in

structure to those described for all other experiments.

The

number of lesions formed, however, appeared to be higher in
the mice actually infected with H. microstoma.

A possible

reason for this could be that the amount of metabolic byproducts available to cause lesion formation might have been
much higher in the mice infected with H. microstoma than in
the experimental mice which were administered worm metabolic
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by-products.
The variation in the number of experimental mice which
had liver lesions, in the different groups, could have been
the result of individual susceptibility and/or genetic makeup.

This was suggested by the differences in the number of

lesions formed among the various experimental mice.

It ap-

peared that the ICR/DUB strain mice were somewhat more resistant to metabolic by-products lesion formation than were
the outbred strain mice.

Variation in responses among groups

of the same strain could have been due to environmental
changes such as stress, temperature, humidity, and other
factors which were not controlled with the limited facilities
available for animal care.
A correlation between the effects of metabolic by-products of H. microstoma on liver lesion formation and the
clinical symptoms of a human infection of H. nana, a serious
public health problem when found in small children,

is pos-

sibly suggested by the results obtained in the present study.
Larsh (1964) reported the clinical symptoms of a human infection of H. nana as being abdominal pain, diarrhea, lack
of appetite, insomnia, irritability, dizziness, and rarely
epileptiform convulsions.

Larsh also reported that these

symptoms are generally accepted, though not proven, to be
due to the absorption of metabolites produced by the cestodes
located in the intestinal tract.

The present study seems

therefore to indicate that the clinical symptoms accompanying
a human infection of H. nana could be due to the absorption
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into the blood stream of worm metabolic by-products, causing
a generalized toxemia.
Additional evidence pointing to the possibility of the
effects of worm metabolic by-products in a human infection
of H. nana as well as the possibility of actual human infections of H. microstoma, although none have ever been reported, is the close relationship of these two cestodes.

In

1961, Dvorak, et al. reported a striking similarity between
the eggs of H. nana and H. microstoma, which apparently can
only be distinguished by scrutinous microscopic examination
by highly trained technicians.
two-fold:

The difference is primarily

(1) a very minute size difference in the eggs

themselves, and (2) a difference in the number of polar filaments found within the embryophore of the embryonated egg.
Thus, it does not seem unreasonable to assume, since the
anatomy and embryogenesis of the two worms are so closely
associated, that the aspect of metabolite formation would
also possibly be quite similar.

Since a fecal smear in which

eggs would be found is the positive diagnostic test for
either cestode, a technician could easily mistake H.
microstoma eggs for H. nana eggs or vice versa.
The conventional treatment for H. nana, an intestional
cestode, would not be entirely effective for an infection
with H. microstoma, in which the majority of the worm is
located in the common bile duct with only part of the gravid
proglottid section of the strobila located in the upper intestional tract.

Consequently, the study of the worm meta-
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bolic by-products of these two cestodes may lead to important
discoveries in the field of public health in respect to
helminth parasite diseases.
The present study also revealed that the causative
agent is a relatively stable compound of low molecular weight
and thus would allow for a relatively easy research topic
with which to work.

This makes possible many research

approaches with respect to liver lesion formation in mice
using the metabolic by-products of H. microstoma.

For

example, the causative agent due to its stability could be
easily concentrated and analyzed biochemically in several
different ways such as determination of exact molecular
weight and organic composition.

As suggested earlier,

metabolic by-products of sexually mature worms, from which
only immature proglottids were taken, could be used to
determine if the causative agent is actually produced only
by immature proglottids.

Another area of study could be the

administration of worm metabolic by-products to different
strains of mice or perhaps to different age and weight mice
to determine the factors which play a role in host susceptibility to lesion formation.

SUMMARY

This research showed that metabolic by-products from 10day -old Hymenolepis microstoma worms, when given to 2 different strains of mice by 2 different routes of administration, resulted in formation of lesions in the parenchyma of
the liver of the experimental mice.

Similar lesions were

formed in an outbred laboratory strain and an inbred ICR/DUB
strain of mouse, when given metabolic by-products by either
intraperitoneal injection or per os intubation.
Worm metabolic by-products from 30-day-old worms did
not appear to cause lesions in the liver of the experimental
mice.

This could have been due to the experimental proce-

dure used; therefore, further studies need to be conducted
concerning the age and type of Froglottids of worms from
which the metabolic by-products are taken.
Further studies showed that the lesion-causing substance
could be isolated in a lipid extract of the metabolic byproducts.

Molecular weight studies showed that the causative

agent appeared to have a molecular weight of less than 10,000.
Lesions formed as a result of administration of metabolic
by-products of H. microstoma were comparable to lesions formed
as a result of an infection with H. microstoma.
cates a common causative agent.
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This indi-
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Finally, this study gave some support to the assumption
that metabolic by-products of cestodes, such as Hymenolepis
nana, when found in humans, may actually be the causative
agent(s) of clinical symptoms which accompany the infection.
This knowledge could become significant in the field of
public health.
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